Immediate Loading of 4 Guided Implants Supporting a Maxillary Overdenture Using a Novaloc TiN Retention System
NCT ID: NCT06083506
Last Updated: 2025-07-20
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2019-01-03
2023-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Partially-guided Protocol for Maxillary Overdentures Retained by Ti-Zr One-piece Mini Implants
NCT06081192
Clinical Investigation of Mandibular Implant Overdenture
NCT00066014
Immediate Versus Delayed Loading of Maxillary Overdenture Implants
NCT06038487
Implant Retained Rehabilitation With Surgical and Prosthetic Digital Workflow
NCT04066309
Effectiveness of Removable Prosthesis Retained by 4 Implant-supported Locator-Attachments
NCT02380404
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NOVALOC TiN
Each subject will receive 4 implants. Implants will be placed flapless using a guided surgical protocol and will be immediately loaded by means of a NOVALOC TiN retained maxillary overdenture.
NOVALOC TiN retained maxillary overdenture
4 implants immediately loaded by means of a NOVALOC TiN retained maxillary overdenture
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NOVALOC TiN retained maxillary overdenture
4 implants immediately loaded by means of a NOVALOC TiN retained maxillary overdenture
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The implant site has to be healed for at least 4 months after extraction
* Wearing complete dentures deemed adequate
* Orthopantomogram available (OPT)
* Adequate amount of bone at least at the 2nd premolar position to house a 3.75 x 10 mm implant
* No bone grafting required
* Implant IT ≥ 20 N/cm
Exclusion Criteria
* Conditions requiring prolonged use of steroids
* History of leukocyte dysfunction and deficiencies
* Bleeding disorders
* History of neoplastic disease requiring use of radiation or chemotherapy
* Metabolic bone disorders
* Uncontrolled endocrine disorder
* Use of any investigational drug or device within the 30-day period prior to implant surgery
* Smoking more than 10 cigarettes a day
* Alcoholism or drug abuse
* Patient infected with HIV
* Condition or circumstances, in the opinion of the investigator, which would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance, unreliability.
* Local inflammation including untreated periodontitis
* Mucosal disease such as erosive lichen planus
* History of local irradiation therapy
* Osseous lesion
* Severe bruxism and clenching habits
* Active infection with suppuration or fistula track
* Persistent intraoral infection
* Lack of primary stability \<20Ncm. In this instance, the patient must be withdrawn and treated according to the standard protocol.
* Inadequate oral hygiene or unmotivated home care.
* Bone grafting
* Inadequate bone volume for implants insertion as measured on the per-treatment CBCT.
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Straumann AG
INDUSTRY
West Virginia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arif Salman, BDS, MDSc
Role: PRINCIPAL_INVESTIGATOR
West Virginia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
West Virginia University
Morgantown, West Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1801929813
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.